Mariner’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
17,974
+10,812
+151% +$453K ﹤0.01% 1913
2026
Q1
$231K Buy
7,162
+139
+2% +$5.14K ﹤0.01% 3073
2025
Q4
$296K Buy
+7,023
New +$283K ﹤0.01% 2860
2025
Q2
Sell
-11,430
Closed -$339K 3701
2025
Q1
$339K Buy
11,430
+2,442
+27% +$93.1K ﹤0.01% 2512
2024
Q4
$356K Buy
8,988
+2,077
+30% +$78.6K ﹤0.01% 2469
2024
Q3
$235K Sell
6,911
-3,285
-32% -$92.4K ﹤0.01% 2791
2024
Q2
$221K Buy
+10,196
New +$214K ﹤0.01% 2710
2024
Q1
Sell
-7,571
Closed -$208K 3247
2023
Q4
$208K Buy
+7,571
New +$183K ﹤0.01% 2659

Other funds holding VCYT

Mariner's VCYT Position: Q2 2026 in Review

Mariner increased its Veracyte (VCYT) stake by 151% in Q2 2026, buying an estimated $453K and bringing the position to 17,974 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

Mariner first reported a position in VCYT in Q4 2023 and has held it in 8 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Mariner held 17,974 shares of Veracyte worth $1.06M as of Q2 2026.
  • Mariner bought 10,812 Veracyte shares in Q2 2026, an estimated $453K.
  • Veracyte made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1913 holding.
  • Mariner first reported a position in Veracyte in Q4 2023 and has held it in 8 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.